Janus Henderson Group PLC Vanda Pharmaceuticals Inc. Transaction History

Janus Henderson Group PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $21 - $32	5 Added 0.02%	24,887 $107,000
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $153 - $180	-26 Reduced 0.1%	24,882 $163,000
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $85,049 - $109,958	13,762 Added 123.47%	24,908 $169,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $151 - $188	16 Added 0.14%	11,146 $110,000
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $288,079 - $366,365	-30,943 Reduced 73.55%	11,130 $122,000
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $335,357 - $512,007	30,937 Added 277.81%	42,073 $476,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $174,723 - $235,415	11,136 New	11,136 $175,000
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $1.04 Million - $1.57 Million	-77,171 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $73,382 - $103,726	7,511 Added 10.78%	77,171 $1.01 Million
Q3 2020 Nov 16, 2020	BUY	$9.32 - $12.02 $61,083 - $78,779	6,554 Added 10.39%	69,660 $673,000
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $292,089 - $363,448	30,237 Added 91.99%	63,106 $722,000
Q1 2020 May 14, 2020	BUY	$7.5 - $16.8 $246,517 - $552,199	32,869 New	32,869 $341,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $247M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.